ArticleFrontiers in pharmacology2022

CYT387, a JAK-Specific Inhibitor Impedes Osteoclast Activity and Oophorectomy-Induced Osteoporosis

Jing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.